UI 068
Alternative Names: UI-068Latest Information Update: 12 Jan 2024
At a glance
- Originator Korea United Pharm Inc
- Class Antihyperglycaemics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Type 2 diabetes mellitus
Most Recent Events
- 11 Mar 2023 Phase-I clinical trials in Type 2 diabetes mellitus (In volunteers) in South Korea (unspecified route) (NCT06141590)